KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Neogenomics (NEO) FCF Margin (2016 - 2025)

Historic FCF Margin for Neogenomics (NEO) over the last 17 years, with Q4 2025 value amounting to 3.43%.

  • Neogenomics' FCF Margin fell 23900.0% to 3.43% in Q4 2025 from the same period last year, while for Dec 2025 it was 2.99%, marking a year-over-year increase of 21600.0%. This contributed to the annual value of 2.99% for FY2025, which is 21600.0% up from last year.
  • Neogenomics' FCF Margin amounted to 3.43% in Q4 2025, which was down 23900.0% from 0.3% recorded in Q3 2025.
  • Over the past 5 years, Neogenomics' FCF Margin peaked at 7.72% during Q2 2025, and registered a low of 31.8% during Q1 2022.
  • Moreover, its 5-year median value for FCF Margin was 9.11% (2021), whereas its average is 10.49%.
  • Per our database at Business Quant, Neogenomics' FCF Margin crashed by -208800bps in 2021 and then surged by 193400bps in 2022.
  • Neogenomics' FCF Margin (Quarter) stood at 25.26% in 2021, then skyrocketed by 77bps to 5.93% in 2022, then surged by 216bps to 6.9% in 2023, then crashed by -115bps to 1.05% in 2024, then tumbled by -228bps to 3.43% in 2025.
  • Its FCF Margin stands at 3.43% for Q4 2025, versus 0.3% for Q3 2025 and 7.72% for Q2 2025.